Biological Resource Center Phoenix serves as a vital hub for preserving, managing, and distributing biological materials critical to research and public health. This facility supports genomics, diagnostics, and longitudinal studies by maintaining high quality standards and traceable sample provenance.
Organizations and investigators rely on centralized infrastructure to coordinate sample workflows, meet regulatory expectations, and accelerate discovery. The center in Phoenix is designed to streamline access to biospecimens while ensuring security, compliance, and reproducible data practices.
Operational Overview and Capabilities
| Facility Attribute | Specification | Compliance Reference | Supported Services |
|---|---|---|---|
| Primary Location | Phoenix, AZ, United States | Federal and State Guidelines | Sample receipt, storage, and distribution |
| Plasma, serum, DNA, RNA, tissues, PBMCs | ISO 17025, CLIA | Cryopreservation, aliquoting, nucleic acid extraction | |
| Inventory Capacity | Up to 500,000 tracked biospecimens | 21 CFR Part 11, GMP | Barcode tracking, LIMS integration, chain of custody |
| Quality Management | Documented SOPs, proficiency testing | ISO 9001, CAP | Stability studies, lot-specific QC reports |
Core Infrastructure and Logistics
Advanced cold chain systems, validated freezers, and controlled-rate freezing protocols ensure sample integrity from collection through long-term storage. Redundant power, continuous environmental monitoring, and automated inventory software provide real-time visibility and rapid recovery in case of disruption.
Security layers include biometric access controls, video surveillance, and audit trails that record every movement of materials within the Biological Resource Center Phoenix. These measures align with best practices for material accountability, supporting traceability for clinical trials and multi-site studies.
Data Management and Informatics
Integrated Laboratory Information Management Systems (LIMS) link sample metadata, test results, and storage locations into a unified platform. Researchers can query de-identified datasets, generate custom reports, and retrieve aliquots with minimal manual intervention, reducing turnaround time for experiments.
Metadata standards, controlled vocabularies, and cross-platform interoperability enable data sharing across institutions. This approach strengthens reproducibility, supports meta-analyses, and facilitates regulatory submissions that require comprehensive documentation of source and handling conditions.
Regulatory and Ethical Considerations
Compliance with HIPAA, GDPR, and relevant biospecimen regulations guides consent management and privacy safeguards. The center maintains robust de-identification procedures, donor authorization tracking, and audit-ready documentation to address ethical and legal expectations.
Partnerships with academic, government, and commercial entities are governed by formal agreements that outline responsibilities around data ownership, publication rights, and commercial use. Clear governance frameworks help align incentives and mitigate conflicts of interest while promoting collaborative innovation.
FAQ
What types of biospecimens can be stored at Biological Resource Center Phoenix?
The center accommodates plasma, serum, DNA, RNA, tissues, and peripheral blood mononuclear cells (PBMCs), with validated protocols for cryopreservation and nucleic acid stabilization.
How is sample identity and chain of custody maintained within the facility?
Each specimen is assigned a unique barcode linked to a centralized LIMS, recording collection time, source, processing steps, and storage location, supported by biometric access logs and continuous inventory tracking.
What compliance standards does the Biological Resource Center Phoenix follow?
The facility adheres to ISO 17025, CLIA, 21 CFR Part 11, ISO 9001, and CAP requirements, ensuring rigorous quality management, method validation, and regulatory readiness for clinical and research workflows.
Can researchers access de-identified data and request custom sample processing?
Yes, approved investigators can query de-identified metadata, leverage informatics tools for cohort selection, and request tailored aliquoting, extraction, or stability studies under defined service agreements.
Strategic Value and Recommendations
- Leverage centralized storage to reduce local infrastructure costs and ensure consistent quality controls.
- Implement standardized metadata capture early to maximize data reusability across future projects.
- Establish clear data-sharing agreements to clarify intellectual property and publication rights with partners.
- Regularly participate in external proficiency testing to validate assay performance and maintain accreditation.
- Plan long-term storage strategies with scalability in mind to accommodate growing specimen volumes and evolving regulatory landscapes.